Cardiac fibroblasts in myocardial injury and heart failure

Area of Science:

• Cardiovascular Biology
• Cellular and Molecular Medicine
• Fibrosis Research

Background:

• Cardiac fibrosis significantly contributes to heart failure progression.
• Aberrant extracellular matrix deposition impairs cardiac function.
• Limited understanding of fibroblast heterogeneity hinders effective anti-fibrotic treatments.

Purpose of the Study:

• To review the evolving understanding of cardiac fibroblast biology in myocardial fibrosis.
• To emphasize fibroblast roles in inflammation and extracellular matrix dysregulation.
• To highlight emerging therapeutic strategies targeting cardiac fibroblasts.

Main Methods:

• Review of recent literature on cardiac fibrosis and fibroblast biology.
• Integration of findings from lineage tracing and single-cell omics studies.
• Analysis of fibroblast interactions with cardiomyocytes and endothelial cells.

Main Results:

• Fibroblasts are diverse stromal cells crucial for cardiac tissue homeostasis and pathological remodeling.
• Distinct fibroblast states and dynamic roles in fibrosis are increasingly recognized.
• Technological advances are unraveling fibroblast complexity in the heart.

Conclusions:

• Understanding fibroblast heterogeneity is critical for developing targeted anti-fibrotic therapies.
• Emerging strategies focus on selectively modulating fibroblast activity.
• Mechanosensitive therapies represent a promising avenue for treating cardiac fibrosis.